This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peipp, M. Articles by Fey, G. H. Search for Related Content PubMed PubMed Citation Articles by Peipp, M. Articles by Fey, G. H.

A Recombinant CD7-specific Single-Chain Immunotoxin Is a Potent Inducer of Apoptosis in Acute Leukemic T Cells¹

Chair of Genetics [M. P., H. K., D. S., S. J. Z., G. H. F.], Institute of Biochemistry [B. S.], Division of Hematology/Oncology, Department of Medicine III [M. G.], University of Erlangen-Nuremberg, D-91054 Erlangen, Germany, and Department of Pediatric Oncology, Children’s Hospital, University of Tübingen, D-72076 Tübingen, Germany [J. G.]

A recombinant immunotoxin was constructed from the hybridoma antibody TH-69 directed against human CD7, a surface antigen of leukemic T cells. The antibody was subcloned as a single chain Fv (scFv) fragment and genetically linked to a truncated Pseudomonas exotoxin A fragment containing the catalytic domains II and III but lacking the receptor binding domain I. Domain I was replaced by the scFv, thus conferring restricted specificity for CD7-positive cells. The bacterially expressed and purified toxin retained binding specificity for CD7-positive cells. It promoted apoptosis in two CD7-positive cell lines derived from T-lineage acute lymphoblastic leukemias, CEM and Jurkat, but not in the CD7-negative B-lymphoid lines REH, Nalm-6, and SEM. Maximum killing in excess of 95% was reached after 96 h in CEM and Jurkat cells with a single dose of 100 ng/ml. Cells treated with a similarly constructed scFv-exotoxin A immunotoxin against melanoma-associated chondroitin sulfate proteoglycan, an antigen absent from leukemic T cells, remained unaffected. Lysis of target cells occurred via apoptosis as evidenced by staining with Annexin V and specific cleavage of poly(ADP-ribose) polymerase. Approximately 20% of leukemic cells from a patient with CD7-positive acute T-cell leukemia kept in long-term primary culture for 30 cell generations were killed within 96 h after treatment with the toxin. These findings justify further evaluation of the agent in view of potential therapeutic applications.

This article has been cited by other articles:

				Y. Guettinger, K. Barbin, M. Peipp, J. Bruenke, M. Dechant, H. Horner, D. Thierschmidt, T. Valerius, R. Repp, G. H. Fey, et al. A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and Fc{alpha}RI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells J. Immunol., February 1, 2010; 184(3): 1210 - 1217. [Abstract] [Full Text] [PDF]

				E. Bremer, B. t. Cate, D. F. Samplonius, L. F. M. H. de Leij, and W. Helfrich CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia Blood, April 1, 2006; 107(7): 2863 - 2870. [Abstract] [Full Text] [PDF]

				E. Bremer, D. F. Samplonius, M. Peipp, L. van Genne, B.-J. Kroesen, G. H. Fey, M. Gramatzki, L. F.M.H. de Leij, and W. Helfrich Target Cell-Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7 Cancer Res., April 15, 2005; 65(8): 3380 - 3388. [Abstract] [Full Text] [PDF]

				P. Lang, K. Barbin, T. Feuchtinger, J. Greil, M. Peipp, S. J. Zunino, M. Pfeiffer, R. Handgretinger, D. Niethammer, and G. H. Fey Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts Blood, May 15, 2004; 103(10): 3982 - 3985. [Abstract] [Full Text] [PDF]

				E. Weidmann, M. Gramatzki, M. Wilhelm, and P. S. Mitrou Diagnosis and actual therapy strategies in peripheral T-cell lymphomas: summary of an international meeting Ann. Onc., March 1, 2004; 15(3): 369 - 374. [Full Text] [PDF]

				M. K. Tur, M. Huhn, T. Thepen, M. Stocker, R. Krohn, S. Vogel, E. Jost, R. Osieka, J. G. van de Winkel, R. Fischer, et al. Recombinant CD64-Specific Single Chain Immunotoxin Exhibits Specific Cytotoxicity against Acute Myeloid Leukemia Cells Cancer Res., December 1, 2003; 63(23): 8414 - 8419. [Abstract] [Full Text] [PDF]